Norditropin ® is a prescription medicine that contains human growth hormone and is used to treat: children who are not growing because of low or no growth hormone; children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 ...

Norditropin ® is a prescription medicine that contains human growth hormone and is used to treat: children who are not growing because of low or no growth hormone; children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 ...

Get to know why many of our patients prefer to use injection pens to self-administer HGH. Here we will bring the comparison of different devices of popular Growth Hormone brands, such as Pfizer, Novo Nordisk, Elli Lilly etc.

May 30, 2000 · GENOTROPIN is a prescription product for the replacement of growth hormone in adults with growth hormone deficiency (GHD) that started either in childhood or as an adult. Your doctor should do tests to be sure you have GHD, as appropriate.

May 30, 2000 · Growth hormone deficiency can be caused by brain tumors. So, the presence of these brain tumors should be ruled out before treatment is started. Growth hormone should not be used if it is shown that a previous brain tumor has come back or is getting larger.

Jun 1, 2019 · Norditropin ® (somatropin) injection is available as FlexPro ® prefilled pens and is the only daily growth hormone therapy approved for 7 indications. 2-8. a Based on Komodo’s Healthcare Map ™ as of February 2024.

For pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH) and Prader-Willi Syndrome; short stature associated with Noonan Syndrome, Turner Syndrome, and children born small for gestational age; idiopathic short stature; and for the replacement of endogenous GH in adults with growth hormone deficienc...

Indicated for the treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone (GH). Indicated for the treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS). The diagnosis of PWS should be confirmed by appropriate genetic testing (see CONTRAINDICATIONS).

FlexPro ® can be used with Novo Nordisk ultra-thin, ultra-short needles – including NovoTwist ®, NovoFine ®, and NovoFine ® Autocover ® – designed for ease of use and less pain and anxiety during injection. Please ask your doctor for more information. FlexPro® is a registered trademark of Novo Nordisk Health Care AG.

Put a personal stamp on your growth with complimentary charms and stickers you can add to your FlexPro ® pen. By signing up, you’ll also get access to parent perspectives and insider tips about living with a growth hormone disorder.